Biotech

All Articles

Orion to use Aitia's 'electronic identical twins' to discover brand new cancer cells medications

.Finnish biotech Orion has actually snooped potential in Aitia's "electronic double" specialist to c...

Windtree's surprise med increases high blood pressure in most up-to-date stage 2 gain

.While Windtree Therapeutics has struggled to increase the monetary roots needed to have to survive,...

2 cancer cells biotechs combine, generating worldwide impact

.OncoC4 is actually taking AcroImmune-- as well as its own internal scientific manufacturing capabil...

Amgen files initial period 3 win for $400M dermatitis drug

.Amgen has actually shared (PDF) the first period 3 data on its own $400 thousand dermatitis medicin...

Biogen, UCB document period 3 lupus win after failing earlier trial

.Biogen and also UCB's bet one's bottom dollar advancing in to period 3 astride a broken research st...

Aptadir really hopes brand new RNA inhibitors can turn around difficult cancers cells

.Italian biotech Aptadir Therapeutics has actually launched with the promise that its pipe of precli...

Wave surfs DMD results to regulatory authorities' doors, sending stock up

.Wave Lifestyle Sciences has met its own objective in a Duchenne muscle dystrophy (DMD) research, po...

Sanofi picks new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold...

Achilles drips tissue therapy course, supports for layoffs after skipping 'industrial stability' goals

.Achilles Therapies has actually wrecked its own strategy. The English biotech is knocking off on it...

Aligos advertises period 2 MASH win, reducing liver excess fat approximately 46%

.Aligos Therapies is actually trumpeting a midstage succeed in metabolic-dysfunction associated stea...